专业人士所感知的COVID-19大流行期间老年痴呆症患者面临的挑战:采访的定性研究
Kaori Kojima1,2, Yoshihisa Hirakawa3,4, Takashi Yamanaka5
1Department of Community Health and Preventive Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
概括
患有痴呆症的老年人由于安全措施和社会隔离,在COVID-19大流行期间经历了严重的精神痛苦. 家庭干预护理决策也对他们的福祉产生了负面影响.
科学领域:
- 老年学是一门学科.
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 以前的研究表明,在COVID-19大流行期间,老年人的心理健康状况下降.
- 有限研究全面探索COVID-19期间痴呆症患者的行为和心理症状的原因.
- 这项研究的重点是识别疫情期间老年痴呆症患者面临的挑战.
研究的目的:
- 在COVID-19大流行期间,识别老年痴呆症患者面临的挑战.
- 了解COVID-19预防措施对痴呆症患者心理健康的影响.
- 探索家庭干预在痴呆症患者医疗服务利用中的作用.
主要方法:
- 使用与医疗保健专业人员进行个别深入采访的定性方法.
- 在2022年1月至3月期间收集的数据.
- 感应手动编码和定性内容分析以确定主题.
主要成果:
- 四个主要主题出现了:对个人防护设备 (PPE) 的恐惧,孤独,对行为限制和视频通话限制的不满,以及家庭对服务使用的干扰.
- 提取了61个独特的语义单元,分为七个类别,并进一步合成为四个主要主题.
- 分析显示,痴呆症患者中存在明显的社会隔离和孤独感.
结论:
- 针对COVID-19的预防措施导致痴呆症患者的精神痛苦,由于缺乏理解而加剧.
- 社会隔离和孤独是这群人面临的重大问题.
- 家庭经常忽视痴呆症患者在医疗保健服务方面的需求和决定.
相关概念视频
01:30Cognitive Development During Adulthood
93
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
93
01:30Dementia
111
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
111
01:26Alzheimer's Disease: Overview
465
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
465
01:28Current Trends in Nursing I
1.5K
Current trends in nursing include:
1.5K
01:26Aging
48
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
48
01:22Alzheimer's Disease: Treatment
180
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
180